Quelicin — Class III drug recall D-0836-2016
Ongoing recall by Hospira Inc., reported 2016-05-11, distributed nationwide. Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be
| Recall number | D-0836-2016 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Hospira Inc., Lake Forest, IL, United States |
| Recall initiated | 2016-03-15 |
| Classified | 2016-05-04 |
| Reported by FDA | 2016-05-11 |
| Distributed | Nationwide (US) |
| Quantity | 103,600 vials |
| Reason classes | foreign material, labeling |
| NDC | 00409-6629, 00409-6629-02, 00409-6629-12 |
| Lot numbers | 52-045-EV |
| Expiration dates | 2016-07-01 |
Product
Quelicin (Succinylcholine Chloride) Injection, USP 200 mg. (20 mg/mL), 10 mL Multiple-dose vial, packaged in 25 Unit vials per carton, Rx only, HOSPIRA, INC., LAKE FOREST, IL 60045 USA, NDC 0409-6629-02
Reason for recall
Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for the lot number and/or expiration date to be faded or missing from the primary label on the glass vial.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0836-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.